IGC Pharma(DE:IGS1)
€0.16-0.02 (-9.50%)
DE:IGS1
IGC Pharma earnings date
€0.16
At close:-0.02 (-9.50%)
IGC Pharma (IGS1) Q2 2027 Earnings Report
6 Followers
DE:IGS1 Q2 2027 EPS Results
- Actual EPS
- -EUR 0.02
- Consensus EPS
- -EUR 0.02
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -EUR 0.02
DE:IGS1 Q2 2027 Revenue Results
- Actual Revenue
- EUR 297.55K
- Expected Revenue
- EUR 87.09K
- Beat/Miss
- Beat by +EUR 210.46K
- YoY Revenue Growth
- +71.73%
Earnings Announcement Details
- Quarter
- Q2 2027
- Date
- 11/09/2026
- Time
- Before Open
- Conference Call
- Monday, November 9, 2026
DE:IGS1 Upcoming Earnings
IGC Pharma's next earnings date is estimated for February 5, 2027, based on past reporting schedules.
Q2 2027 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2027 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2027 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:IGS1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 05, 2027 | 2027 (Q3) | -0.02- | -0.01 | ― | ― |
| Nov 09, 2026 | 2027 (Q2) | -0.02-0.02 | -0.02 | 0.00% (+0.00) | |
| Jun 15, 2026 | 2026 (Q4) | ―-0.02 | -0.02 | 0.00% (+0.00) | |
| Mar 19, 2026 | 2026 (Q3) | -0.02-0.01 | -0.02 | 50.00% (+0.01) | |
| Nov 17, 2025 | 2026 (Q2) | -0.02-0.02 | -0.02 | 0.00% (+0.00) | |
| Aug 19, 2025 | 2026 (Q1) | ―- | -0.03 | ― | |
| Jun 30, 2025 | 2025 (Q4) | -0.02-0.02 | -0.03 | 33.33% (+0.01) | |
| Feb 18, 2025 | 2025 (Q3) | -0.03-0.02 | -0.08 | 77.78% (+0.06) | |
| Nov 14, 2024 | 2025 (Q2) | -0.03-0.02 | -0.05 | 60.00% (+0.03) | |
| Aug 09, 2024 | 2025 (Q1) | -0.03-0.03 | -0.04 | 23.08% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
